<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31348" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Whipple Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Antunes</surname>
            <given-names>Catiele</given-names>
          </name>
          <aff>Johns Hopkins Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singhal</surname>
            <given-names>Mayank</given-names>
          </name>
          <aff>Cape Fear Valley, Methodist University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Catiele Antunes declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mayank Singhal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31348.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The gram-positive bacterium, Tropheryma whipplei causes Whipple disease. Whipple disease is a systemic disorder that not only involves malabsorption from the gastrointestinal tract but also affects other systems like the cardiovascular, central nervous system, joints, and vascular system. Early disease recognition will decrease the morbidity and mortality of Whipple disease. This activity covers the importance of making an accurate diagnosis of Whipple disease. Moreover, it highlights the role of teams in caring for patients afflicted with Whipple disease.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the most common disease comorbidities associated with Whipple disease.</p></list-item><list-item><p>Identify the psychosocial considerations for patients with Whipple disease.</p></list-item><list-item><p>Describe the approach to performing a comprehensive history and physical examination for patients with Whipple disease.</p></list-item><list-item><p>Summarize the interprofessional team's strategies for improving care coordination and communication to advance the management of Whipple disease and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31348&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31348">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31348.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Whipple disease&#x000a0;is caused&#x000a0;by a gram-positive bacteria,&#x000a0;<italic toggle="yes">Tropheryma whippelii</italic>.&#x000a0;This is a systemic disorder that not only involves malabsorption from the gastrointestinal tract&#x000a0;but also&#x000a0;affects&#x000a0;other systems like the cardiovascular, central nervous system, joints, and vascular system. Dr. George Hoyt Whipple initially described this condition in 1907. He was the first American Nobel Prize laureate in Physiology. Dr. Whipple described a case of a 36-year-old&#x000a0;male&#x000a0;who presented with malabsorption associated with mesenteric lymphadenopathy, arthralgias, and skin pigmentation. The condition&#x000a0;named by him "Intestinal Lipodystrophy," and his article&#x000a0;was&#x000a0;published in the Bulletin of Johns Hopkins Hospital.&#x000a0;He hypothesized that&#x000a0;an infectious agent was responsible, but&#x000a0;the bacteria was only fully identified in 1992.<xref ref-type="bibr" rid="article-31348.r1">[1]</xref><xref ref-type="bibr" rid="article-31348.r2">[2]</xref><xref ref-type="bibr" rid="article-31348.r3">[3]</xref></p>
        <p>Whipple disease is rare, and only case reports exist in the literature.</p>
      </sec>
      <sec id="article-31348.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Tropheryma whipplei&#x000a0;</italic>was described in 1992. It was named <italic toggle="yes">Tropheryma whippelii&#x000a0;</italic>until 2001, when its name was modified to conform with the proper spelling of Dr. George Hoyt Whipple's name. It is a gram-positive bacillus, periodic acid-Schiff-positive (PAS), and acid-fast negative. Electron microscopy showed that the bacillus core is enclosed&#x000a0;within a plasma membrane, which is surrounded by a three-layered cell wall. The inner layer contains polysaccharides that stain positive with PAS. The outer layer resembles a plasma membrane and may be of host origin, which possibly accounts for the failure of the host to mount a humoral antibody response to the infection.</p>
      </sec>
      <sec id="article-31348.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Globally, Whipple disease is a rare disorder with most reports published in North America and Europe. The disorder is associated with the HLA B27 haplotype. The overall incidence of Whipple disease is about one to three in every one million people. The mean age of onset of symptoms is age 55. It is much more frequent in males than in females, with a ratio of 4:1. The organism seems to be soil-dwelling which explains the increased prevalence in farmers.<xref ref-type="bibr" rid="article-31348.r4">[4]</xref></p>
      </sec>
      <sec id="article-31348.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The&#x000a0;detailed pathogenesis remains unclear, but there is enough evidence to believe that&#x000a0;host immunity plays an important role.&#x000a0;Most individuals who contract <italic toggle="yes">T. whippelii&#x000a0;</italic>are asymptomatic carriers or develop a limited infection with subsequent development&#x000a0;of protective&#x000a0;humoral and cellular immunity.&#x000a0;In&#x000a0;diseased individuals, the inflammatory response to the organism is muted. It consists primarily of altered macrophage function and activation and an impaired type 1 T-cell response.&#x000a0;Whipple bacillus shares antigenic similarity with <italic toggle="yes">Streptococcal</italic> groups B and G and with <italic toggle="yes">Shigella flexneri. </italic>Host factors play an important pathogenic role as suggested by the two to threefold increase in the frequency of HLA-B27 antigen among affected individuals.<xref ref-type="bibr" rid="article-31348.r5">[5]</xref></p>
        <p>The organism is ingested by macrophages which can be observed PAS. Unfortunately, PAS-stained macrophages are not pathognomonic for Whipple disease. Electron microscopy may reveal coccobacillus bodies that reflect the organism.</p>
        <p>The malabsorption seen is due to disruption of the normal villus function. If systemic disease develops, the organism can be found in many tissues.</p>
      </sec>
      <sec id="article-31348.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Whipple disease is characterized by myriad findings&#x000a0;related to the infectious involvement of several organ systems. The typical presentation includes gastrointestinal symptoms that resemble other malabsorption syndromes. The prominent&#x000a0;symptoms are weight loss, diarrhea, arthralgias, fever, and abdominal pain. Diarrhea has the usual features of steatorrhea but may be watery. Occult gastrointestinal bleeding is common (up to 80% of patients). Gross bleeding can also be present sometimes.</p>
        <p>Peripheral edema reflects hypoproteinemia from protein-losing enteropathy and poor nutrition. Arthralgias are migratory, nondestructive, and involve large joints. They often precede intestinal manifestation. The articular attacks are usually acute in onset and last for hours to days. Sacroiliitis is common (20% to 30%), but ankylosing spondylitis is rare. Fever is also present in 30% to 50% of patients.</p>
        <p>At some point, at least one-third of patients will have involvement of the heart. Pericarditis and endocarditis are common (50% to 75%) but rarely produce&#x000a0;significant symptoms. Apical systolic murmurs are detected in 25% of patients. Friction&#x000a0;rubs and congestive heart failure develop in up to 10% of patients.&#x000a0;Patients who develop central nervous system (CNS) involvement may have signs of frontal release, ataxia, or clonus. Supranuclear ophthalmoplegia has also been reported in the medical literature.</p>
        <p>Other neurological features described in these patients include confusion, seizures, delirium, cognitive impairment, abnormal body movements, hypersomnia, and extrapyramidal symptoms. Post-mortem&#x000a0;examination reveals that&#x000a0;the central nervous&#x000a0;system&#x000a0;is affected in 90% of patients, but clinical involvement&#x000a0;becomes evident in only 10% to 40% of patients. Physical examination of patients will reveal peripheral lymphadenopathy in about 50% of the cases. Hyperpigmentation around the malar and orbital areas, hyperkeratosis, purpura, abdominal distension, glossitis, cheilitis, gingivitis, Chovstek or Trousseau sign&#x000a0;can also be seen.&#x000a0;<xref ref-type="bibr" rid="article-31348.r6">[6]</xref></p>
      </sec>
      <sec id="article-31348.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of Whipple disease is made by a biopsy of the intestine and identification of the organism.&#x000a0;Current diagnostic criteria require&#x000a0;positive results for PAS-positive foamy macrophages in the small bowel biopsy. If it is negative, the diagnosis can also be made by showing positive results in for&#x000a0;two of&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>PAS staining showing foamy&#x000a0;macrophages&#x000a0;in a biopsy specimen of involved tissues</p>
          </list-item>
          <list-item>
            <p>PCR Detection of <italic toggle="yes">T. whippelii&#x000a0;</italic>or detection of the specific 16S rRNA of the bacterium</p>
          </list-item>
          <list-item>
            <p>Immunohistochemical staining with <italic toggle="yes">T. whippelii&#x000a0;</italic>antibodies</p>
          </list-item>
        </list>
        <p>It is important&#x000a0;to know that&#x000a0;<italic toggle="yes">T. whippelii&#x000a0;</italic>quickly becomes&#x000a0;negative after the&#x000a0;initiation of therapy, which may lead to false negatives since many patients receive antibiotics before undergoing extensive diagnostic testing for this condition.&#x000a0;Other lab findings include anemia in 90% of cases and results from chronic disease, iron deficiency,&#x000a0;and folate or vitamin B12 deficiency. Neutrophilia is present in one-third of patients. Mild lymphocytopenia is common. Eosinophilia and thrombocytopenia&#x000a0;rarely occur. Hypoalbuminemia is prevalent, whereas serum globulin levels are normal. The prothrombin time is prolonged. Steatorrhea occurs in 93% of cases.<xref ref-type="bibr" rid="article-31348.r3">[3]</xref></p>
      </sec>
      <sec id="article-31348.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The mainstay of treatment for&#x000a0;Whipple disease&#x000a0;is&#x000a0;antibiotic therapy. Because of the&#x000a0;possibility of CNS involvement, even in the absence of symptoms, the use of antibiotics that penetrate the blood-brain barrier is desirable. One recommended regimen&#x000a0;for the initial phase is Ceftriaxone two grams daily or Penicillin G two million units&#x000a0;every four&#x000a0;hours. The usual duration for the initial phase is two weeks, followed by the maintenance phase with Trimethoprim 160 mg- Sulfamethoxazole 800 mg twice daily for twelve months. Meropenem can also be used for the initial phase in patients with penicillin allergy. Long courses are usually necessary to prevent relapse. Unfortunately, relapse can occur even years after treatment.&#x000a0;Often, CNS symptoms may be the first sign of relapse.<xref ref-type="bibr" rid="article-31348.r7">[7]</xref><xref ref-type="bibr" rid="article-31348.r8">[8]</xref></p>
        <p>It is important to note that after the initial parenteral treatment, at least 12 months of treatment is required with oral trimethoprim-sulfamethoxazole.</p>
        <p>Body fluids must be evaluated for the organism to ensure a complete cure, which can take 1 to 2 years.</p>
      </sec>
      <sec id="article-31348.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses of Whipple disease include:</p>
        <list list-type="bullet">
          <list-item>
            <p>HIV</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease with arthropathy</p>
          </list-item>
          <list-item>
            <p>Connective tissue disorder</p>
          </list-item>
          <list-item>
            <p>Hyperthyroidism.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31348.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Usually, the prognosis is good with prompt diagnosis and treatment of Whipple disease. The patients feel a lot better within two to three weeks of initiation of the treatment.<xref ref-type="bibr" rid="article-31348.r9">[9]</xref></p>
        <p>Untreated patients have a poor prognosis.</p>
      </sec>
      <sec id="article-31348.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Whipple disease is a progressively&#x000a0;debilitating disease if it gets undiagnosed and untreated. Complications from untreated&#x000a0;Whipple disease are mainly due to nutritional&#x000a0;deficiencies as it interferes with the absorption process of the small intestine. Few disseminated cases of Whipple disease sepsis&#x000a0;have also been reported. Irreversible&#x000a0;brain damage and potential death&#x000a0;can also occur.&#x000a0;</p>
      </sec>
      <sec id="article-31348.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Due to the need for small bowel biopsy and the&#x000a0;treatment with long-term antibiotics, Gastroenterology and infectious disease should be consulted.</p>
      </sec>
      <sec id="article-31348.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The prompt diagnosis and successful&#x000a0;treatment&#x000a0;of Whipple disease require an interprofessional approach&#x000a0;involving internal medicine, gastroenterology, and infectious disease specialists to work in a coordinated manner with nursing and pharmacy staff.</p>
        <p>The diagnosis of Whipple disease is not straightforward, as the disorder is rare and the symptoms are vague. Many organs can be involved, and hence awareness is vital. The treatment of Whipple disease requires antibiotics for 1 to 2 years, and hence, an infectious disease board-certified pharmacist may consult on the case, helping the clinicians focus antibiotic therapy appropriately. The pharmacist must also educate the patient on compliance. Premature discontinuation can lead to relapse and progression of the infection into other tissues. Regular clinic&#x000a0;follow-ups are also critical due to the prolonged course of treatment; this is where the nursing staff is crucial, charting progress, counseling the patient and answering questions, recognizing potential adverse drug reactions, and informing the clinicians of any concerns. Because of the rarity of the disorder, the team should clearly communicate with each other so that the patient receives the current standard of care.</p>
      </sec>
      <sec id="article-31348.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31348&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31348">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/whipple-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31348">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31348/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31348">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31348.s15">
        <title>References</title>
        <ref id="article-31348.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fitzgibbons</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Histochemistry in the diagnosis of non-neoplastic gastrointestinal disorders.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>370</fpage>
            <page-range>370-380</page-range>
            <pub-id pub-id-type="pmid">30366790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31348.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frickmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hanke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Landt</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Moter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kikhney</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hinz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rojak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dekker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tannich</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Podbielski</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Detection of Tropheryma whipplei in stool samples by one commercial and two in-house real-time PCR assays.</article-title>
            <source>Trop Med Int Health</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-108</page-range>
            <pub-id pub-id-type="pmid">30347125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31348.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crews</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Cawcutt</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Pritt</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Virk</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Approach for Classic Compared With Localized Whipple Disease.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>7</issue>
            <fpage>ofy136</fpage>
            <pub-id pub-id-type="pmid">29992176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31348.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dolmans</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Boel</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lacle</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kusters</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>529</fpage>
            <page-range>529-555</page-range>
            <pub-id pub-id-type="pmid">28298472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31348.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hujoel</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Lebwohl</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Leffler</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kupfer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rubio-Tapia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Tropheryma whipplei Infection (Whipple Disease) in the USA.</article-title>
            <source>Dig Dis Sci</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>213</fpage>
            <page-range>213-223</page-range>
            <pub-id pub-id-type="pmid">29572616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31348.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bally</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>M&#x000e9;neret</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roze</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grabli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of movement disorders and oculomotor abnormalities in Whipple's disease.</article-title>
            <source>Mov Disord</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>1700</fpage>
            <page-range>1700-1711</page-range>
            <pub-id pub-id-type="pmid">30338868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31348.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Whipple's disease].</article-title>
            <source>Dtsch Med Wochenschr</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>139</volume>
            <issue>49</issue>
            <fpage>2507</fpage>
            <page-range>2507-9</page-range>
            <pub-id pub-id-type="pmid">25423457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31348.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hagel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Epple</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Feurle</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Kern</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Lynen Jansen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Malfertheiner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marth</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mielke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>von M&#x000fc;ller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nattermann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nothacker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pox</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reisinger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Salzberger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Salzer</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weinke</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Suerbaum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lohse</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Stallmach</surname>
                <given-names>A</given-names>
              </name>
              <collab>Weitere Mitglieder der Leitlinienkommission sind am Ende des Beitrags gelistet</collab>
            </person-group>
            <article-title>[S2k-guideline gastrointestinal infectious diseases and Whipple's disease].</article-title>
            <source>Z Gastroenterol</source>
            <year>2015</year>
            <month>May</month>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>418</fpage>
            <page-range>418-59</page-range>
            <pub-id pub-id-type="pmid">25965989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31348.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meunier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Puechal</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hopp&#x000e9;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Soubrier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dieud&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Berthelot</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Caramaschi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gottenberg</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Gossec</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Morel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maury</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wipff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Allanore</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Rheumatic and musculoskeletal features of Whipple disease: a report of 29 cases.</article-title>
            <source>J Rheumatol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>12</issue>
            <fpage>2061</fpage>
            <page-range>2061-6</page-range>
            <pub-id pub-id-type="pmid">24187107</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
